Pfizer’s RSV Vaccine: US FDA Panel Wants Robust Safety Program With Public Accountability

 
• By Sarah Karlin-Smith
babies
Pfizer’s maternal RSV vaccine got positive VRBPAC votes on 18 May • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers